āagmanLoginNot investment advice. Data and computed figures, for information only.
Niva Bupa Health Insurance Company Ltd
₹76.01
−₹2.58 (−3.28%)
NSE · 15 Oct 2026, close
Market Cap
₹14,359 Cr
CMP
₹76.01
52-wk High / Low
₹91 / 68
P/E
82.4
P/B
3.8
Book Value
₹20.5
Div Yield
0.00%
ROCE
3.0%
ROE
3.5%
Face Value
₹10
D/E
0.07
Price−4.2% over 1Y
āagman read
Computed by āagmanPiotroski F-Score
5
/ 9
5 of 9 F-score tests passed
Graham Number
₹18
√(22.5 × EPS × book value per share)
ROIC
3.1%
vs 10.0% sector median
Cash flow to profit
6.91
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+237
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
3.5%
ROE × earnings retention ratio
ROE stability
17.1
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom −0.06FII +1.49DII −0.32
Latest quarter vs the previous one
Cash-accrual divergence
−7.4%
of assets
Low = accruals track cash flow
Strengths
+Annualised volatility of 23.6% is in the low band (≤25%)
Watch-outs
−Latest ROCE of 3% trails the sector median of 9.4%
−Price trades below its 200-day moving average (1.0x)
Peer comparison
| Name | P/E | Mar Cap ₹ Cr | ROCE % | ROE % |
|---|
Quarterly results
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 969 | 1,026 | 1,316 | 1,124 | 1,321 | 1,258 | 1,671 | 1,932 | 1,574 | 1,611 | 2,251 | 2,471 |
| Expenses | 1,027 | 1,071 | 1,215 | 1,228 | 1,387 | 1,282 | 1,420 | 1,834 | 1,627 | 1,705 | 2,069 | 2,287 |
| Operating Profit | −58 | −46 | 100 | −103 | −66 | −24 | 251 | 98 | −53 | −94 | 182 | 184 |
| OPM % | −6.0% | −4.5% | 7.6% | −9.2% | −5.0% | −1.9% | 15.0% | 5.1% | −3.4% | −5.8% | 8.1% | 7.4% |
| Other Income | 50 | 50 | 57 | 84 | 79 | 37 | −45 | 0 | 18 | 7 | −1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −8 | 5 | 157 | −19 | 13 | 13 | 206 | 98 | −35 | −88 | 181 | 184 |
| Net Profit | −8 | 5 | 157 | −19 | 13 | 13 | 206 | 71 | −35 | −88 | 159 | 138 |
| EPS (₹) | — | — | — | — | — | 0.07 | 1.13 | 0.39 | −0.19 | −0.47 | 0.86 | 0.75 |
Profit & Loss
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 851 | 1,057 | 1,413 | 1,877 | 2,853 | 4,115 | 5,374 | 6,695 | 7,907 |
| Expenses | 880 | 1,094 | 1,435 | 2,328 | 3,183 | 4,228 | 5,292 | 6,534 | 7,689 |
| Operating Profit | −29 | −37 | −22 | −451 | −330 | −113 | 83 | 160 | 218 |
| OPM % | −3.4% | −3.5% | −1.6% | −24.0% | −11.6% | −2.7% | 1.5% | 2.4% | 2.8% |
| Other Income | 0 | 0 | 0 | 281 | 374 | 224 | 155 | 2 | 23 |
| Interest | 3 | 4 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 16 | 21 | 22 | 27 | 32 | 29 | 25 | 36 | 0 |
| Profit before tax | −48 | −62 | −50 | −197 | 13 | 82 | 214 | 127 | 242 |
| Net Profit | −48 | −62 | −50 | −197 | 13 | 82 | 214 | 131 | 174 |
| EPS (₹) | — | — | — | — | — | — | 1.17 | 0.71 | 0.95 |
Balance Sheet
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 981 | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 | 1,827 | 1,847 | — |
| Reserves | −719 | −780 | −773 | −903 | −683 | 351 | 1,949 | 1,939 | — |
| Borrowings | 0 | 0 | 0 | 250 | 250 | 250 | 250 | 250 | — |
| Other Liabilities | 737 | 891 | 1,322 | 1,983 | 2,799 | 3,891 | 5,735 | 7,240 | — |
| Total Liabilities | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 11,276 | — |
| Fixed Assets | 30 | 39 | 46 | 49 | 52 | 58 | 66 | 85 | — |
| CWIP | 2 | 2 | 2 | 1 | 4 | 1 | 9 | 3 | — |
| Investments | 816 | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 | 8,175 | 9,670 | — |
| Other Assets | 152 | 129 | 230 | 287 | 455 | 675 | 1,510 | 1,518 | — |
| Total Assets | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 11,276 | — |
Cash Flows
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | — | — | 257 | 338 | 593 | 813 | 1,654 | 905 |
| Cash from Investing Activity | — | — | −374 | −723 | −829 | −1,882 | −2,348 | −961 |
| Cash from Financing Activity | — | — | 280 | 374 | 280 | 1,110 | 771 | −5 |
| Net Cash Flow | — | — | 164 | −12 | 43 | 41 | 78 | −62 |
Ratios
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| ROCE % | — | −19.0 | −10.0 | −30.0 | 1.0 | 5.0 | 7.0 | 3.0 |
| ROE % | — | — | — | — | — | — | — | 3.5 |
| EPS (₹) | — | — | — | — | — | — | 1.17 | 0.71 |
| Book Value (₹) | — | — | — | — | — | — | — | 20.5 |
| Face Value (₹) | — | — | — | — | — | — | — | 10 |
| P/E | — | — | — | — | — | — | — | 82.4 |
| Div Yield % | — | — | — | — | — | — | — | 0.00 |
| NPM % | −5.6 | −5.9 | −3.5 | −9.1 | 0.4 | 1.9 | 3.9 | 2.0 |
| OPM % | −3.4 | −3.5 | −1.5 | −24.0 | −12.0 | −2.7 | 1.5 | 2.4 |
| D/E | 0.00 | 0.00 | 0.00 | 0.49 | 0.30 | 0.12 | 0.07 | 0.07 |
| P/B | — | — | — | — | — | — | — | 3.8 |
Growth
Compounded sales growth
5 years+36.0%
3 years+33.0%
TTM+28.0%
Compounded profit growth
5 years+36.0%
3 years+127.0%
TTM−43.0%
Stock price CAGR
Last year−2.0%
Return on equity
5 years3.0%
3 years5.0%
Last year3.0%
Documents
Announcements
Board Meeting Outcome for Outcome Of Debt Raising Committee Meeting Held On October 09, 2026.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Board Meeting Intimation for To Consider Alteration Of Date Of Payment Of Interest Or Redemption AmountClosure of Trading WindowAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationCorporate actions
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman